Ambu Past Earnings Performance
Past criteria checks 3/6
Ambu's earnings have been declining at an average annual rate of -5.1%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 11.4% per year. Ambu's return on equity is 4.2%, and it has net margins of 4.4%.
Key information
-5.1%
Earnings growth rate
-7.4%
EPS growth rate
| Medical Equipment Industry Growth | -9.5% |
| Revenue growth rate | 11.4% |
| Return on equity | 4.2% |
| Net Margin | 4.4% |
| Next Earnings Update | 30 Jan 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Ambu makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5,391 | 235 | 2,231 | 325 |
| 30 Jun 24 | 5,263 | 450 | 2,183 | 321 |
| 31 Mar 24 | 5,075 | 367 | 2,119 | 312 |
| 31 Dec 23 | 4,897 | 238 | 2,130 | 300 |
| 30 Sep 23 | 4,775 | 168 | 2,116 | 295 |
| 30 Jun 23 | 4,679 | -42 | 2,151 | 293 |
| 31 Mar 23 | 4,612 | -65 | 2,160 | 290 |
| 31 Dec 22 | 4,545 | 95 | 2,146 | 286 |
| 30 Sep 22 | 4,444 | 93 | 2,151 | 281 |
| 30 Jun 22 | 4,307 | 222 | 2,113 | 274 |
| 31 Mar 22 | 4,152 | 256 | 2,065 | 255 |
| 31 Dec 21 | 4,031 | 176 | 2,001 | 242 |
| 30 Sep 21 | 4,013 | 247 | 1,938 | 225 |
| 30 Jun 21 | 3,858 | 251 | 1,861 | 210 |
| 31 Mar 21 | 3,832 | 281 | 1,810 | 198 |
| 31 Dec 20 | 3,820 | 290 | 1,760 | 174 |
| 30 Sep 20 | 3,567 | 241 | 1,627 | 157 |
| 30 Jun 20 | 3,302 | 146 | 1,462 | 126 |
| 31 Mar 20 | 3,128 | 270 | 1,301 | 111 |
| 31 Dec 19 | 2,924 | 296 | 1,134 | 106 |
| 30 Sep 19 | 2,820 | 317 | 1,054 | 103 |
| 30 Jun 19 | 2,943 | 515 | 1,000 | 103 |
| 31 Mar 19 | 2,843 | 411 | 962 | 111 |
| 31 Dec 18 | 2,709 | 372 | 920 | 114 |
| 30 Sep 18 | 2,606 | 337 | 872 | 111 |
| 30 Jun 18 | 2,506 | 318 | 848 | 104 |
| 31 Mar 18 | 2,434 | 288 | 824 | 90 |
| 31 Dec 17 | 2,396 | 281 | 804 | 82 |
| 30 Sep 17 | 2,355 | 301 | 790 | 76 |
| 30 Jun 17 | 2,299 | 306 | 747 | 71 |
| 31 Mar 17 | 2,215 | 299 | 726 | 69 |
| 31 Dec 16 | 2,134 | 267 | 711 | 68 |
| 30 Sep 16 | 2,084 | 250 | 700 | 66 |
| 30 Jun 16 | 2,047 | 224 | 715 | 65 |
| 31 Mar 16 | 2,012 | 169 | 700 | 61 |
| 31 Dec 15 | 1,963 | 175 | 692 | 58 |
| 30 Sep 15 | 1,889 | 152 | 665 | 55 |
| 30 Jun 15 | 1,795 | 171 | 616 | 53 |
| 31 Mar 15 | 1,710 | 184 | 597 | 50 |
| 31 Dec 14 | 1,630 | 156 | 564 | 45 |
| 30 Sep 14 | 1,584 | 151 | 556 | 44 |
| 30 Jun 14 | 1,543 | 94 | 548 | 42 |
| 31 Mar 14 | 1,524 | 67 | 543 | 40 |
| 31 Dec 13 | 1,456 | 40 | 524 | 39 |
Quality Earnings: AMBUBC has a large one-off loss of DKK334.0M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: AMBUBC's current net profit margins (4.4%) are higher than last year (3.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMBUBC's earnings have declined by 5.1% per year over the past 5 years.
Accelerating Growth: AMBUBC's earnings growth over the past year (39.9%) exceeds its 5-year average (-5.1% per year).
Earnings vs Industry: AMBUBC earnings growth over the past year (39.9%) exceeded the Medical Equipment industry 39.9%.
Return on Equity
High ROE: AMBUBC's Return on Equity (4.2%) is considered low.